Posttransplant Autoimmune Hemolytic Anemia and Other Autoimmune Cytopenias are Increased in Very Young Infants Undergoing Unrelated Donor Umbilical Cord Blood Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 10, 2008, Pages 1108-1117

  Page, Kristin M ^a   Mendizabal, Adam M ^b   Prasad, Vinod K ^a   Martin, Paul L ^a   Parikh, Suhag ^a   Wood, Susan ^a   Sempowski, Gregory D ^a   Szabolcs, Paul ^a   Kurtzberg, Joanne ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

Autoimmune hemolytic anemia; Chronic graft versus host disease; Unrelated umbilical cord blood transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; BUSULFAN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOGLOBULIN; MESNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD DONOR; CELL DESTRUCTION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOPENIA; DRUG DOSE ESCALATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GENETIC DISORDER; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; IMMUNE DYSREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; LOW DRUG DOSE; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; MYCOSIS; NEUTROPENIA; PANCYTOPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PNEUMOCYSTIS PNEUMONIA; SEIZURE; SPLENECTOMY; THROMBOCYTOPENIA; UMBILICAL CORD BLOOD; VEIN OCCLUSION;

ANEMIA; ANEMIA, HEMOLYTIC, AUTOIMMUNE; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMOGLOBINOPATHIES; HISTOCOMPATIBILITY; HUMANS; INFANT; INFANT, NEWBORN; LYSOSOMAL STORAGE DISEASES; PANCYTOPENIA; THROMBOCYTOPENIA; TRANSPLANTATION CONDITIONING;

EID: 51649107049     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.07.006     Document Type: Article

References (30)

1. Filipovich A., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (2005) 945-955
2. Couriel D., Carpenter P., Cutler C., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 12 (2006) 375-396
3. Drobyski W., Potluri J., Sauer D., and Gottschall J. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 17 (1996) 1093-1099
4. Chen F., Owen I., Savage D., et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 19 (1997) 491-495
5. Sanz J., Arriaga F., Montesinos P., et al. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 39 (2007) 555-561
6. Horn B., Viele M., Mentzer W., Mogck N., DeSantes K., and Cowan M. Autoimmune hemolytic anemia in patients with SCID after T-cell depleted BM and PBSC transplantation. Bone Marrow Transplant 24 (1999) 1009-1013
7. O'Brien T., Eastlund T., Peters C., et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated transplants for non-malignant diseases. Br J Haematol 127 (2004) 67-75
8. Martin P.L., Carter S.L., Kernan N.A., et al. Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 12 (2006) 184-194
9. Kurtzberg J., Balber A., Mendizabal A., et al. Preliminary results of a pilot trial of unrelated umbilical cord blood transplantation (UCBT) augmented with cytokine-primed aldehyde dehydrogenase-bright (ALDHbr) cells. Blood 108 (2006) abst 3641
10. Rubinstein P., Dobrila L., Rosenfield R., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92 (1995) 10119-10122
11. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute gvhd grading. Bone Marrow Transplant 15 (1995) 825-828
12. Gooley T., Leisenring W., Crowley J., and Storer B. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
13. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
14. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
15. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
16. Prasad V.K., and Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 41 (2008) 99-108
17. Godder K., Pati A., Abhyankar S., Lamb L., Armstrong W., and Henslee-Downey P. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant 19 (1997) 813-817
18. Raj A., Bertolone S., and Cheerva A. Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 26 (2004) 312-314
19. Corti P., Bonanomi S., Vallinoto C., et al. Rituximab for immune hemolytic anemia following T- and B-cell-depleted hematopoietic stem cell transplantation. Acta Haematol 109 (2003) 43-45
20. Hall J., Martin P., Wood S., and Kurtzberg J. Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol 26 (2004) 382-385
21. Urban C., Benesch M., Sovinz P., Schwinger W., and Lackner H. Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome. Eur J Haematol 72 (2004) 444-447
22. Dovat S., Roberts R., Wakim M., Stiehm E., and Feig S. Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine. Bone Marrow Transplant 24 (1999) 321-323
23. Pratt G., and Kinsey S. Remission of severe, intractable, autoimmune haemolytic anaemia following matched unrelated donor transplantation. Bone Marrow Transplant 28 (2001) 791-793
24. Mullen C., Thompson J., Richard L., and Chan K. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia. Bone Marrow Transplant 25 (2000) 1093-1099
25. Sevilla J., Gonzalez-Vicent M., Madero L., and Diaz M. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 28 (2001) 89-92
26. Hongeng S., Tardtong P., Worapongpaiboon S., Ungkanont A., and Jootar S. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplant 29 (2002) 871-872
27. Tubman V.N., Smoot L., and Heeney M.M. Acquired immune cytopenias post-cardiac transplantation respond to rituximab. Pediatric Blood Cancer 48 (2006) 339-344
28. Rawal A., Sarode R., Curtis B.R., Karandikar N.J., Friedman K., and Rogers Z.R. Acquired Glanzmann's Thrombasthenia as part of multiple-autoantibody syndrome in a pediatric heart transplant patient. J Pediatr (2004) 672-674
29. Hess A., and Thoburn C. Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells. Biol Blood Marrow Transplant 12 (2006) 518-529
30. Zeiser R., Nguyen V., Beilhack A., et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108 (2006) 390-399